Drug Profile
Research programme: anthrax-ricin vaccine - Soligenix
Alternative Names: Ricin-anthrax vaccine - Soligenix; RiVax™ plus VeloThrax™Latest Information Update: 22 Jun 2021
Price :
$50
*
At a glance
- Originator Soligenix
- Class Anthrax vaccines; Subunit vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants; Toll-like receptor 4 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Anthrax; Ricin poisoning
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for preclinical development in Anthrax(Prevention) in USA
- 28 Sep 2018 No recent reports of development identified for preclinical development in Ricin poisoning(Prevention) in USA
- 19 Aug 2014 Research programme: anthrax-ricin vaccine - Soligenix is available for licensing in World as of 19 Aug 2014. www.soligenix.com